Table 11.

Reported outcome in studies on treatment of primary knee osteoarthritis with autologous, adipose-derived regenerative cells, or autologous, adipose-derived stem cells listed in Table 10.

R	FA	Reported Outcome
Autologous ADRCs
[19]	Garza	WOMAC total score at BL and at W6, M3, M6 and M12 (mean, median, interquartile range, median percentage range, minimum, maximum) Cartilage loss (mean at BL, mean change at M6) Outerbridge classification (median at BL, range at BL, median change at M6)
[52]	Koh	VAS pain score (mean and SD at baseline and at last follow-up) KOOS sub-scores (mean improvement from BL to LFU) Lysholm score (mean and SD at BL and LFU) Weight-bearing line (%) (mean and SD at BL and LFU) Femorotibial angle (°) (mean and SD at BL and LFU)
Autologous ADSCs
[18]	Lee	VAS pain score at BL, M3 and M6 (mean) WOMAC total and sub-scores at BL, M3 and M6 (mean) KOOS sub-scores at BL, M3 and M6 (mean) Size of cartilage defect in MRI at BL and M6 (mean, SD)
[30]	Freitag	VAS pain score at BL, M1,5, M3, M6 and M12 (mean, 95% CI) KOOS sub-scores at BL, M1,5, M3, M6 and M12 (mean, 95% CI) WOMAC score at BL, M1,5, M3, M6 and M12 (mean, 95% CI)
[56]	Zhang	VAS pain score at BL, M3, M6, M12, M24 and M36 (mean, SD) WOMAC total score at BL, M3, M6, M12, M24 and M36 (mean, SD)
[60]	Qiao	SF-36 Physical Component and Mental Component sub-scores at BL, M3, M6, M9, M12 and M24 (mean, SD)

Abbreviations: ADRCs, adipose-derived regenerative cells; ADSCs, adipose-derived stem cells; R, reference; FA, first author; BL, baseline; W6, 6 weeks post treatment; M3/M6/M9/M12/M24, three/six/nine/twelve/24 months post-treatment; LFU, last follow-up (range, M14–M24; mean: M19.8); SD, standard deviation; and CI, confidence interval.